Market Tracker

10/24 2:02pm ET

Orexigen Therapeutics Inc (NASDAQ:OREX)

4.39
Real-Time Quote
 +0.01 / +0.23%
Today’s Change
3.11
Today|||52-Week Range
7.82
-22.02%
Year-to-Date

Today’s Trading

Previous close4.38
Today’s open4.40
Day’s range4.30 - 4.41
Volume1,135,258
Average volume (3 months)4,212,873
Market cap$536.7M
Dividend yield--
Data as of 1:47pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)+37.01%
Earnings growth (this year)+92.50%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales158.47
Price/Book10.98

Competitors

 Today’s
change
Today’s
% change
MGNXMacroGenics Inc-0.48-2.44%
SPPISpectrum Pharmaceuti...-0.05-0.70%
PRTAProthena Corporation...+0.23+1.12%
FLMLFlamel Technologies ...-0.07-0.54%
Data as of 1:46pm ET, 10/24/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$3.4M
Annual profit (last year)-$77.7M
Net profit margin-2,265.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
CFO, Treasurer &
Chief Business Officer
Joseph P. Hagan
Corporate headquarters
La Jolla, California

Forecasts